Felix Moser is a biological engineer with a PhD in Biological Engineering from the Massachusetts Institute of Technology. They currently serve as a Senior Research Scientist at AbCellera, where they focus on antibody engineering and various display techniques. Previously, Felix held the position of CEO at Synlife, leading the development of biotherapeutic formulations and fostering strategic partnerships. Their academic journey includes a Joint MS in Bioengineering from UC Berkeley and UCSF, alongside significant contributions in synthetic biology and drug delivery during their postdoctoral research.
This person is not in the org chart
This person is not in any teams
This person is not in any offices